Vincent Perrone | Director, Corporate Communication |
Steven Shallcross | Chief Executive and Financial Officer |
Michael Kaleko | Senior Vice President-Research and Development |
Vince Wacher | Head-Product and Corporate Development |
James Molloy | Alliance Global Partners |
Michael Okunewitch | Maxim Group |
Good afternoon, and welcome to Synthetic Biologics’ 2021 Second Quarter Investor Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. At this time, I would like to turn the call over to Mr. Vincent Perrone, Director of Corporate Communication at Synthetic Biologics.